Two model compounds 4,4′-[sulfonylbis(4′-phenyleneoxy-4-phenylene)]-bis[1,2-dihydro-1-oxo-2-phenyl-(2H)-phthalazine] (13)and 4-(4-methoxyphenyl)-1-(4-methylphenoxy)phthalazine (17) for the respective lactam and lactim forms of 1,2-dihydro-4-(4-hydroxyphenyl)-1-oxo-(2H)-phthalazine (5) were synthesized. They were used as guides in the structural analysis of polymer 9 resulting from the reaction of 5 with bis(4-fluorophenyl)sulfone (8) carried out in N-methyl-2-pyrrolidinone at 170°C for 6 hours utilizing K2CO3 as the basic catalyst. The interpretations were largely done by 1H and 13C NMR and, qualitatively, by FT-IR and UV spectroscopy. For the key model compounds 13 and 17 and polymer 9, all of the carbons were conclusively assigned aided by H-COSY, H-C HETCOR, HMQC, and HMBC NMR techniques. The results reveal that species 5 bonds with 8 at the 2-aza-nitrogen atom of the phthalazine moiety with its lactam tautomer as the only detectable form in polymer 9. The multiple lines shown by several carbons in the 13C-NMR spectrum of 9 and their similar geometrical shapes strongly indicate that there are perhaps four magnetically different environments of the repeat unit which are randomly arranged in the chain of polymer 9.
No takes yet. Share an insight, caveat, or question.
Paventi et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: